Patient awareness of serious consequences of non-adherence to antiplatelet therapy after coronary stenting

doi:10.1016/j.ijcard.2012.09.147

International Journal of Cardiology

Volume 166, Issue 1, 5 June 2013, Pages 278-279

https://doi.org/10.1016/j.ijcard.2012.09.147 Get rights and content

References (8)

C.L. Grines et al.
Prevention of premature discontinuation of dual antiplatelet therapy in patients with coronary artery stents. A science advisory from the American Heart Association, American College of Cardiology, Society for Cardiovascular Angiography and Interventions, American College of Surgeons and American Dental Association, with representation from the American College of Physicians
J Am Dent Assoc
(2007)
N.H. Miller
Compliance with treatment regimens in chronic asymptomatic diseases
Am J Med
(1997)
C.L. Poh et al.
Prevalence and predictors of premature discontinuation of dual antiplatelet therapy after drug-eluting stent implantation: importance of social factors in Asian patients
Intern Med J
(2011)
N.H. Miller et al.
The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals
Circulation
(1997)

There are more references available in the full text version of this article.

Cited by (4)

Impact of a web-based intervention on the awareness of medication adherence
2016, Research in Social and Administrative Pharmacy
Citation Excerpt :
From the interventions studied, educational interventions with behavioral support through continued patient contact over an extended period of time led to moderate improvement in medication adherence across various clinical diagnoses.1 Finally, there is a paucity of literature addressing patients' awareness of consequences of nonadherence and the extent to which increasing awareness of nonadherence might determine the effect of interventions.3,4,19,20 Evidence from previous research suggests that pharmacists, through their specialized training and expertise in medications, have been effective agents for improved patient medication adherence.21–24
Medication nonadherence is a widely recognized problem that leads to adverse outcomes and increased health care costs. Reasons for medication nonadherence are multifactorial, and patient awareness of the salience of medication adherence is critical.
The purpose of this research was to assess the impact of a pharmacist-led, web-based video presentation in increasing patients' awareness of the importance of medication adherence.
Patients aged 35 years and above, taking at least 1 chronic prescription medication were included in the study (n = 166). Patients completed a pre-survey, watched a pharmacist-led web-based video presentation educating them on the importance of medication adherence, then completed a 1-month follow-up survey. The primary outcome was measurement of change in patients' awareness of the importance of medication adherence.
Results indicated a statistically significant increase in the primary outcome of increasing awareness of the importance of medication adherence. More patients in the follow-up survey indicated that it was important for their health to take their medications around the same time daily (P = 0.002), and more patients identified that their family will be impacted as a result of their medication nonadherence (P = 0.001) as compared to the pre-survey. More patients in the follow-up survey reported that they expected to experience fewer emergency room visits (P = 0.0001) and anticipated that they would get more time to spend with friends and family (P = 0.0039) as benefits of taking medications as prescribed.
A pharmacist-led web-based video presentation may be a low-cost intervention to increase patients' awareness of the importance of medication adherence.
Acute coronary syndrome in the Asia-Pacific region
2016, International Journal of Cardiology
Citation Excerpt :
Specifically, poor patient education results in poor adherence/compliance with treatment associated with, for example, poor knowledge as to which dose/type of medication missed would present more significant consequences e.g., antiplatelet versus statin. The implementation of post-hospital coaching programmes e.g., the Coaching patients On Achieving Cardiovascular Health (COACH) programme in Australia has been shown to be effective in improving outcomes, both short-term (12 months) and longer-term (4-year follow-up) [87,88]; ‘aware’ patients are eight times more likely to be compliant than their counterparts as to the cardiac risks associated with non-compliance [89]. Along with the possibility the prevalence of non-compliance is likely underestimated due to recall bias and self under-reporting [89], improved patient education through sustained educational initiatives remains a key target for improving outcomes.
More than 4.2 billion inhabitants populate the Asia-Pacific region. Acute coronary syndrome (ACS) is now a major cause of death and disability in this region with in-hospital mortality typically exceeding 5%. Yet, the region still lacks consensus on the best approach to overcoming its specific challenges in reducing mortality from ACS. The Asia-Pacific Real world evIdenCe on Outcome and Treatment of ACS (APRICOT) project reviewed current published and unpublished registry data, unmet needs in ACS management and possible approaches towards improving ACS-related mortality in the region. There was striking heterogeneity in the use of invasive procedures, pharmacologic practice (hospitalization/post-discharge), and in short- and long-term clinical outcomes across healthcare systems; this heterogeneity was perceived to be far greater than in Western Europe or the United States. ‘Benchmark’ short-term clinical outcomes are preferred over long-term outcomes due to difficulties in follow-up, recording and maintenance of medication adherence in a geographically large and culturally diverse region. Key ‘barriers’ towards improving outcomes include patient education (pain awareness, consequences of missing medication and secondary prevention), geographical landscape (urban vs. metropolitan), limited long-term adherence to guideline-based management and widespread adoption of cost-based rather than value-based healthcare systems. Initiatives to overcome these barriers should include implementation of pre-hospital management strategies, toolkits to aid in-hospital treatment, greater community outreach with online patient/physician education and telemedicine, sustainable economic models to improve accessibility to effective pharmacotherapies and the acquisition of high-quality ‘real-world’ regional data to tailor secondary prevention initiatives that meet the unique needs of countries in this region.
Recognition and control of hypertension, diabetes, and dyslipidemia in patients with systemic lupus erythematosus
2018, Clinical Rheumatology
Recognition and control of hypertension, diabetes, and dyslipidemia in patients with rheumatoid arthritis
2018, Rheumatology International

View full text

Letter to the EditorPatient awareness of serious consequences of non-adherence to antiplatelet therapy after coronary stenting

J Am Dent Assoc

Am J Med

Prevalence and predictors of premature discontinuation of dual antiplatelet therapy after drug-eluting stent implantation: importance of social factors in Asian patients

Intern Med J

The multilevel compliance challenge: recommendations for a call to action. A statement for healthcare professionals

Circulation

Letter to the Editor
Patient awareness of serious consequences of non-adherence to antiplatelet therapy after coronary stenting